Imaging of CAR T-cells in cancer patients – paving the way to treatment monitoring and outcome prediction

In 2013, the journal Science named cancer immunotherapy as the “breakthrough of the year” based on targeted approaches using chimeric antigen receptor (CAR) T-cells. CD19-specific CAR T-cell therapy has revolutionized the treatment landscape for patients with relapsed B-cell acute lymphocytic